Jennifer H. Yearley
About
Jennifer H. Yearley is a scholar working on Oncology, Immunology and Pulmonary and Respiratory Medicine.
According to data from OpenAlex, Jennifer H. Yearley has authored 56 papers receiving a total of 5.7k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Oncology, 27 papers in Immunology and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jennifer H. Yearley's work include Cancer Immunotherapy and Biomarkers (36 papers), Immunotherapy and Immune Responses (17 papers) and CAR-T cell therapy research (12 papers). Jennifer H. Yearley is often cited by papers focused on Cancer Immunotherapy and Biomarkers (36 papers), Immunotherapy and Immune Responses (17 papers) and CAR-T cell therapy research (12 papers). Jennifer H. Yearley collaborates with scholars based in United States, Australia and South Korea. Jennifer H. Yearley's co-authors include Terrill K. McClanahan, Erin Murphy, Jared Lunceford, Jonathan D. Cheng, Tanguy Y. Seiwert, Mark Ayers, Michael Nebozhyn, Antoni Ribas, Andrew Albright and Andrey Loboda and has published in prestigious journals such as The Lancet, Journal of Biological Chemistry and Journal of Clinical Investigation.
In The Last Decade
Jennifer H. Yearley
54 papers receiving 5.6k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Jennifer H. Yearley United States | 24 | 3.7k | 2.6k | 1.4k | 1.1k | 664 | 56 | 5.7k | ||
| Brenda J. Weigel United States | 44 | 2.3k 0.6× | 1.4k 0.5× | 1.6k 1.2× | 1.9k 1.8× | 688 1.0× | 164 | 5.8k | ||
| Sophie Piperno‐Neumann France | 41 | 3.5k 0.9× | 975 0.4× | 3.4k 2.5× | 1.7k 1.5× | 889 1.3× | 217 | 6.9k | ||
| Diva R. Salomão United States | 32 | 4.5k 1.2× | 2.9k 1.1× | 1.4k 1.0× | 961 0.9× | 365 0.5× | 143 | 7.5k | ||
| Denise Frosina United States | 23 | 2.3k 0.6× | 1.9k 0.7× | 1.0k 0.8× | 812 0.7× | 443 0.7× | 50 | 4.2k | ||
| Michael Yellin United States | 38 | 4.7k 1.3× | 5.2k 2.0× | 543 0.4× | 1.6k 1.5× | 326 0.5× | 112 | 8.2k | ||
| Cristina Hajdu United States | 26 | 2.0k 0.5× | 1.5k 0.6× | 660 0.5× | 1.2k 1.1× | 585 0.9× | 70 | 4.8k | ||
| Gunhild Mechtersheimer Germany | 41 | 2.5k 0.7× | 1.0k 0.4× | 2.4k 1.7× | 1.8k 1.6× | 896 1.3× | 193 | 6.7k | ||
| Ekaterina S. Jordanova Netherlands | 49 | 3.4k 0.9× | 3.5k 1.3× | 565 0.4× | 1.6k 1.4× | 953 1.4× | 156 | 7.2k | ||
| Andrew J. Long United States | 8 | 2.9k 0.8× | 2.8k 1.0× | 481 0.4× | 688 0.6× | 197 0.3× | 11 | 4.6k | ||
| Enrico Munari Italy | 35 | 1.6k 0.4× | 1.6k 0.6× | 784 0.6× | 926 0.8× | 528 0.8× | 107 | 3.7k |
Countries citing papers authored by Jennifer H. Yearley
Since
Specialization
Citations
This map shows the geographic impact of Jennifer H. Yearley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jennifer H. Yearley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jennifer H. Yearley more than expected).
Fields of papers citing papers by Jennifer H. Yearley
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Jennifer H. Yearley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jennifer H. Yearley. The network helps show where Jennifer H. Yearley may publish in the future.
Co-authorship network of co-authors of Jennifer H. Yearley
This figure shows the co-authorship network connecting the top 25 collaborators of Jennifer H. Yearley. A scholar is included among the top collaborators of Jennifer H. Yearley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jennifer H. Yearley. Jennifer H. Yearley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Dent, Rebecca, Javier Cortés, Eva Muñoz‐Couselo, et al.. (2025). Molecular determinants of response to neoadjuvant pembrolizumab plus chemotherapy in patients with high-risk, early-stage, triple-negative breast cancer: exploratory analysis of the open-label, multicohort phase 1b KEYNOTE-173 study. Breast Cancer Research. 27(1). 35–35.
2.
Tran, Thai Q., Jeff Grein, Mohammed Selman, et al.. (2024). Oncolytic virus V937 in combination with PD-1 blockade therapy to target immunologically quiescent liver and colorectal cancer. SHILAP Revista de lepidopterología. 32(2). 200807–200807.
3.
Bauché, David, Smita Mauze, Christina M. Kochel, et al.. (2020). Antitumor efficacy of combined CTLA4/PD-1 blockade without intestinal inflammation is achieved by elimination of FcγR interactions. Journal for ImmunoTherapy of Cancer. 8(2). e001584–e001584.
4.
Bauché, David, Barbara Joyce-Shaikh, Renu Jain, et al.. (2018). LAG3+ Regulatory T Cells Restrain Interleukin-23-Producing CX3CR1+ Gut-Resident Macrophages during Group 3 Innate Lymphoid Cell-Driven Colitis. Immunity. 49(2). 342–352.e5.
5.
Owen, Dwight H., Benjamin F. Chu, Amy M. Lehman, et al.. (2018). Expression Patterns, Prognostic Value, and Intratumoral Heterogeneity of PD-L1 and PD-1 in Thymoma and Thymic Carcinoma. Journal of Thoracic Oncology. 13(8). 1204–1212.
6.
Yearley, Jennifer H., Christopher J. Gibson, Ni Yu, et al.. (2017). PD-L2 Expression in Human Tumors: Relevance to Anti-PD-1 Therapy in Cancer. Clinical Cancer Research. 23(12). 3158–3167.
7.
Giraldo, Nicolás A., Genevieve J. Kaunitz, Tricia R. Cottrell, et al.. (2017). Abstract 662: The differential association of PD-1, PD-L1, and CD8+ cells with response to pembrolizumab and presence of Merkel cell polyomavirus (MCPyV) in patients with Merkel cell carcinoma (MCC). Cancer Research. 77(13_Supplement). 662–662.
8.
Chen, Meixuan, Mariacarla Andreozzi, Barbara A. Pockaj, et al.. (2017). Development and validation of a novel clinical fluorescence in situ hybridization assay to detect JAK2 and PD-L1 amplification: a fluorescence in situ hybridization assay for JAK2 and PD-L1 amplification. Modern Pathology. 30(11). 1516–1526.
9.
Chandramouleeswaran, Prasanna M., Anna J. Lee, Alain Benitez, et al.. (2016). Preferential Secretion of Thymic Stromal Lymphopoietin (TSLP) by Terminally Differentiated Esophageal Epithelial Cells: Relevance to Eosinophilic Esophagitis (EoE). PLoS ONE. 11(3). e0150968–e0150968.
10.
Dolled‐Filhart, Marisa, Darren Locke, Jennifer H. Yearley, et al.. (2016). Development of a Prototype Immunohistochemistry Assay to Measure Programmed Death Ligand-1 Expression in Tumor Tissue. Archives of Pathology & Laboratory Medicine. 140(11). 1259–1266.
11.
Kakavand, Hojabr, James S. Wilmott, Alexander M. Menzies, et al.. (2015). PD-L1 Expression and Tumor-Infiltrating Lymphocytes Define Different Subsets of MAPK Inhibitor–Treated Melanoma Patients. Clinical Cancer Research. 21(14). 3140–3148.
12.
Pham, Christina, Catherine Flores, Changlin Yang, et al.. (2015). Differential Immune Microenvironments and Response to Immune Checkpoint Blockade among Molecular Subtypes of Murine Medulloblastoma. Clinical Cancer Research. 22(3). 582–595.
13.
Tarhini, Ahmad A., Haris Zahoor, Jennifer H. Yearley, et al.. (2015). Tumor associated PD-L1 expression pattern in microscopically tumor positive sentinel lymph nodes in patients with melanoma. Journal of Translational Medicine. 13(1). 319–319.
14.
Sabbatino, Francesco, Vincenzo Villani, Jennifer H. Yearley, et al.. (2015). PD-L1 and HLA Class I Antigen Expression and Clinical Course of the Disease in Intrahepatic Cholangiocarcinoma. Clinical Cancer Research. 22(2). 470–478.
15.
Kakavand, Hojabr, Ricardo E. Vilain, James S. Wilmott, et al.. (2015). Tumor PD-L1 expression, immune cell correlates and PD-1+ lymphocytes in sentinel lymph node melanoma metastases. Modern Pathology. 28(12). 1535–1544.
16.
Madore, Jason, Ricardo E. Vilain, Alexander M. Menzies, et al.. (2014). PD ‐L1 expression in melanoma shows marked heterogeneity within and between patients: implications for anti‐ PD ‐1/ PD ‐ L 1 clinical trials. Pigment Cell & Melanoma Research. 28(3). 245–253.
17.
Yearley, Jennifer H., et al.. (2009). Interleukin-18 predicts atherosclerosis progression in SIV-infected and uninfected rhesus monkeys (Macaca mulatta) on a high-fat/high-cholesterol diet. Laboratory Investigation. 89(6). 657–667.
18.
Yearley, Jennifer H., Keith G. Mansfield, Angela Carville, et al.. (2008). Antigenic stimulation in the simian model of HIV infection yields dilated cardiomyopathy through effects of TNFα. AIDS. 22(5). 585–594.
19.
Yearley, Jennifer H., Christine B. Pearson, Richard P. Shannon, & Keith G. Mansfield. (2007). Phenotypic Variation in Myocardial Macrophage Populations Suggests a Role for Macrophage Activation in SIV-Associated Cardiac Disease. AIDS Research and Human Retroviruses. 23(4). 515–524.
20.
Yearley, Jennifer H., Christine B. Pearson, Angela Carville, Richard P. Shannon, & Keith G. Mansfield. (2006). SIV-Associated Myocarditis: Viral and Cellular Correlates of Inflammation Severity. AIDS Research and Human Retroviruses. 22(6). 529–540.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Brenda J. Weigel Breakdown of academic impact, for papers by Sophie Piperno‐Neumann Breakdown of academic impact, for papers by Diva R. Salomão Breakdown of academic impact, for papers by Denise Frosina Breakdown of academic impact, for papers by Michael Yellin Breakdown of academic impact, for papers by Cristina Hajdu Breakdown of academic impact, for papers by Gunhild Mechtersheimer Breakdown of academic impact, for papers by Ekaterina S. Jordanova Breakdown of academic impact, for papers by Andrew J. Long Breakdown of academic impact, for papers by Enrico Munari